Monographie - Dexrazoxane hydrochloride

Viimane versioon :
16/06/2024

Dexrazoxane hydrochloride

Keemiline struktuur

Kaubanduslikud nimed erinevates maades

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Cardioxane	Austria, Brasiilia, Ecuador, Hispaania, Iirimaa, Itaalia, Maroko, Mehhiko, Poola, Prantsusmaa, Saksamaa, Suurbritannia, Taani, Tšiili, Ungari, Venetsueela
Cyrdanax	Prantsusmaa, Saksamaa
Dexrazoxane	Ameerika ühendriigid, Ecuador
Dexrazoxano	Maroko, Mehhiko
Razox	Maroko
Razoxane	Kolumbia
Rhianta	Mehhiko
Savene	Belgia, Hispaania, Holland, Iirimaa, Itaalia, Kreeka, Norra, Poola, Prantsusmaa, Rootsi, Rumeenia, Saksamaa, Soome, Suurbritannia, Taani, Ungari
Zinecard	Ameerika ühendriigid, Kanada
Zucordex	Mehhiko

Viited : Dexrazoxane hydrochloride

	Tüüp	Avaldamine
381	Ajaleht	Beijnen JH, Van Gijn R. Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids. J Parenter Sci Technol 1993 ; 47: 166-171.
1423	Ajaleht	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1754	Ajaleht	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1949	Ajaleht	Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Clinical Cancer Research 2001 ; 7: 1569-1576.
1953	Ajaleht	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
2201	Ajaleht	Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. EJHP Science 2007 ; 13, 3: 55-59.
2224	Ajaleht	Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P. Dexrazoxane: Stabilià in soluzione. Bolletino SIFO 2007 ; 53: 178-180.
3581	Labor	Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit Clinigen Healthcare 2013
3611	Ajaleht	Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. J Oncol Pharm Practice 2014 ; 20, 1: 58-64.

Mentions Légales